Literature DB >> 34404954

The need for new test verification and regulatory support for innovative diagnostics.

John D Roback1, Erika A Tyburski2,3, David Alter1, Saja Asakrah1, Ann Chahroudi4,5, Annette Esper6, Sarah Farmer7, Janet Figueroa4, Jennifer K Frediani8, Mark D Gonzalez5, David S Gottfried2, Jeannette Guarner1, Nitika A Gupta4,5, Stacy S Heilman4, Charles E Hill1, Robert Jerris5, Russell R Kempker6, Jessica Ingersoll1, Joshua M Levy9, Maud Mavigner4, Carlos S Moreno1, Claudia R Morris4,5, Eric J Nehl10, Andrew S Neish1, Deniz Peker1, Natia Saakadze1, Paulina A Rebolledo6,10, Christina A Rostad4,5, Nils Schoof4, Allie Suessmith4, Julie Sullivan4, Yun F Wayne Wang1, Anna Wood4, Miriam B Vos4,5, Oliver Brand11, Greg S Martin12, Wilbur A Lam13,14,15,16.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34404954      PMCID: PMC9007716          DOI: 10.1038/s41587-021-01047-7

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


× No keyword cloud information.
  2 in total

1.  Covid-19 Molecular Diagnostic Testing - Lessons Learned.

Authors:  Jeffrey Shuren; Timothy Stenzel
Journal:  N Engl J Med       Date:  2020-09-09       Impact factor: 91.245

2.  Radical solutions.

Authors: 
Journal:  Nat Biotechnol       Date:  2021-04       Impact factor: 54.908

  2 in total
  1 in total

Review 1.  Pivoting Novel Exosome-Based Technologies for the Detection of SARS-CoV-2.

Authors:  Christine Happel; Chariz Peñalber-Johnstone; Danilo A Tagle
Journal:  Viruses       Date:  2022-05-18       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.